研究

Masatoshi Kudo

Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma.

Andreas Teufel, Masatoshi Kudo, Yuquan Qian, Jimmy Daza, Isaac Rodriguez, Christoph Reissfelder, Ezequiel Ridruejo, Matthias P Ebert

Current Trends and Advancements in the Management of Hepatocellular Carcinoma.

Natsuki Okai, Yasuo Otsuka, Sho Masaki, Masatoshi Kudo, Tomohiro Watanabe

Necrotizing Fasciitis of the Serratus Anterior in a Patient Treated With Infliximab and Prednisolone for Ulcerative Colitis and Rheumatoid Arthritis

Andrej Lyshchik, David T Fetzer, Yuko Kono, Stephanie R Wilson, Christoph F Dietrich, Dirk A Clevert, Maria Franca Meloni, Hyun-Jung Jang, Tae Kyoung Kim, Jeong Min Lee …

Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.

Yasuo Otsuka, Kosuke Minaga, Akane Hara, Kentaro Yamao, Mamoru Takenaka, Takaaki Chikugo, Masatoshi Kudo

Early diagnosis of pancreatic cancer via pancreatic juice cytology with a cell-block method in a patient with altered anatomy.

Lindsay M Thornton, Nadine Abi-Jaoudeh, Howard J Lim, Katerina Malagari, Benjamin Oren Spieler, Masatoshi Kudo, Richard S Finn, Riccardo Lencioni, Sarah B White, Nima Kokabi …

Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.

Yu Ki Sim, Ming Chuen Chong, Mihir Gandhi, Yogesh Mahadev Pokharkar, Yanan Zhu, Luming Shi, Li Lequn, Chien-Hung Chen, Masatoshi Kudo, Joon Hyeok Lee …

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study.

Masatoshi Kudo

Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma.

Franco Trevisani, Alessandro Vitale, Agostino Colli, Masatoshi Kudo, Laura Kulik, Joon-Won Park, David J Pinato, Umberto Cillo

EVIDENCE-BASED FAILURE OF STAGE HIERARCHY THERAPEUTIC APPROACH TO HCC.

George Lau, Ghassan K Abou-Alfa, Ann-Lii Cheng, Wattana Sukeepaisarnjaroen, Tu Van Dao, Yoon Koo Kang, Satheesh Chiradoni Thungappa, Masatoshi Kudo, Bruno Sangro, Robin Kate Kelley …

Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Masatoshi Kudo, Richard S Finn, Masafumi Ikeda, Max W Sung, Ari D Baron, Takuji Okusaka, Masahiro Kobayashi, Hiromitsu Kumada, Shuichi Kaneko, Marc Pracht …

A Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.

Masatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, Richard S Finn, Peter R Galle, Michel Ducreux, Ann-Lii Cheng, Tatsuya Yamashita, Hironori Koga, Ryosuke Take …

Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study.

Masatoshi Kudo

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization).

Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Tse-Ching Chen, Susumu Eguchi, Tomoharu Yoshizumi, Shinji Itoh, Noriaki Nakamura …

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.

Yasuo Otsuka, Kosuke Minaga, Akane Hara, Yasuhiro Masuta, Mamoru Takenaka, Takaaki Chikugo, Masatoshi Kudo

Detective flow imaging endoscopic ultrasound for locating optimal puncture site for a poorly vascularized pancreatic mass.

Akane Hara, Tomohiro Watanabe, Kosuke Minaga, Tomoe Yoshikawa, Masayuki Kurimoto, Ikue Sekai, Yasuhiro Masuta, Ryutaro Takada, Yasuo Otsuka, Ken Kamata …

A positive cytokine/chemokine feedback loop establishes plasmacytoid dendritic cell-driven autoimmune pancreatitis in IgG4-related disease

Sho Masaki, Yasuhiro Masuta, Hajime Honjo, Masatoshi Kudo, Tomohiro Watanabe

NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract

Yasuo Otsuka, Ikue Sekai, Yasuhiro Masuta, Kosuke Minaga, Tomohiro Watanabe, Masatoshi Kudo

Clinical practice guidelines for acute pancreatitis in the United States and Japan: similarities and differences

Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Federico Rossari, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier …

Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study.

Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji …

Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice.

Koichiro Kawano, Mamoru Takenaka, Reiko Kawano, Tomonori Moriguchi, Koutaro Mine, Katsuhisa Nishi, Masatoshi Kudo

A technique for preventing clip snagging during the use of a rotating function endoscopic clip.

Shigenaga Matsui, Hiroshi Kashida, Masahiro Takita, Masatoshi Kudo

Endoscopic glue injection therapy with N-butyl-2-cyanoacrylate for bleeding from isolated large rectal varices.

Satoru Hagiwara, Hiroshi Ida, Takaaki Chikugo, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo

Peliosis Hepatis Complicated by Scleroderma and Rapidly Progressing to Liver Failure

Satoru Hagiwara, Itsuki Oda, Kazuomi Ueshima, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Naoya Omaru, Takuya Matsubara, Masatoshi Kudo

A Case of Fibrolamellar Hepatocellular Carcinoma in Which Tumor Control Was Achieved by Re-Administering Atezolizumab and Bevacizumab.

Masatoshi Kudo

Challenges in Adjuvant Immunotherapy after Resection or Ablation for Hepatocellular Carcinoma at High-Risk of Recurrence.

Masatoshi Kudo, Kaoru Tsuchiya, Tatsuya Yamashita, Hironori Koga, Yuki Nakagawa, Masafumi Ikeda

Reply to the Letter Regarding "Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study".

Aoki T, Kudo M

Incidence of hyper progressive disease in combination immunotherapy and anti-PD-1/PD-L1 monotherapy for unresectable hepatocellular carcinoma

Takenaka M, Lee TH, Kudo M

Recent advances in metallic stents used in the stent-in-stent method for hilar malignant biliary obstruction.

Kariyama K, Nouso K, Hiraoka A, Toyoda H, Tada T, Tsuji K, Ishikawa T, Hatanaka T, Itobayashi E, Takaguchi K, Tsutsui A, Naganuma A, Yasuda S, Kakizaki S, Wakuta A, Shiota S, Kudo M

Treatment options for solitary hepatocellular carcinoma ≤5 cm: Surgery vs Ablation: A multicenter retrospective study.

Masuta Y, Minaga K, Otsuka Y, Okai N, Hara A, Masaki S, Nagai T, Honjo H, Kudo M

Cytokine and chemokine profiles in ulcerative colitis relapse after coronavirus disease 2019 vaccination

Okai N, Masuta Y, Otsuka Y, Hara A, Masaki S, Kamata K, Minaga K, Honjo H, Kudo M

Crosstalk between NOD2 and TLR2 suppresses the development of TLR2-mediated experimental colitis.

Satoru Hagiwara, Toru Takase, Itsuki Oda, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo

Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage

Okushin K, Tateishi R, Hirakawa S, Tachimori H, Uchino K, Nakagomi R, Yamada T, Nakatsuka T, Minami T, Sato M, Fujishiro M, Hasegawa K, Eguchi Y, Kanto T, Yoshiji H, Izumi N, Kudo M

The Impact of COVID-19 on the Diagnosis and Treatment of HCC: Analysis of a Nationwide Registry for Advanced Liver Diseases (REAL).

Otuska Y, Minaga K, Kudo M

Role of leucine-rich repeat kinase 2 in severe acute pancreatitis.

Hara A, Minaga K, Otsuka Y, Tanaka H, Takenaka M, Kudo M

Emergency digital cholangioscopy-assisted electrohydraulic lithotripsy for basket impaction with an entrapped bile duct stone.

Hagiwara S, Tanizaki J, Hayashi H, Komeda Y, Nishida N, Yoshida A, Yamamoto T, Matsubara T, Kudo M

Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.

Josep M Llovet, Roser Pinyol, Mark Yarchoan, Amit G Singal, Thomas U Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S Finn

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.

Komeda Y, Tribonias G, Kono M, Handa K, Omoto S, Takenaka M, Hagiwara S, Tsuji N, Nishida N, Kashida H, Kudo M

Real-world data on short-term and long-term treatment results of ustekinumab in patients with steroid-resistant/dependent ulcerative colitis

Kudo M

Objective response to systemic therapy is a strong predictor of overall survival in patients with unresectable hepatocellular carcinoma

Satoru Hagiwara, Koichi Nakagawa, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo

A Case of an Splenic Artery Aneurysm and Focal Nodular Hyperplasia Associated with an Abdominal Vascular Abnormality of Hereditary Hemorrhagic Telangiectasia